PT86233A - Procede de preparation d:une variant de l:hirudine - Google Patents

Procede de preparation d:une variant de l:hirudine

Info

Publication number
PT86233A
PT86233A PT86233A PT8623387A PT86233A PT 86233 A PT86233 A PT 86233A PT 86233 A PT86233 A PT 86233A PT 8623387 A PT8623387 A PT 8623387A PT 86233 A PT86233 A PT 86233A
Authority
PT
Portugal
Prior art keywords
hirudine
variant
preparation
amino acid
variants
Prior art date
Application number
PT86233A
Other languages
English (en)
French (fr)
Other versions
PT86233B (pt
Original Assignee
Transgene Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Transgene Sa filed Critical Transgene Sa
Publication of PT86233A publication Critical patent/PT86233A/pt
Publication of PT86233B publication Critical patent/PT86233B/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/815—Protease inhibitors from leeches, e.g. hirudin, eglin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Physics & Mathematics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Plant Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Materials For Medical Uses (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
PT86233A 1986-12-01 1987-11-27 Processo para a preparacao de uma variante da hirudina PT86233B (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR868616723A FR2607517B2 (fr) 1986-12-01 1986-12-01 Vecteurs d'expression de variants de l'hirudine dans les levures, procede et produit obtenu

Publications (2)

Publication Number Publication Date
PT86233A true PT86233A (fr) 1987-12-01
PT86233B PT86233B (pt) 1990-11-07

Family

ID=9341393

Family Applications (1)

Application Number Title Priority Date Filing Date
PT86233A PT86233B (pt) 1986-12-01 1987-11-27 Processo para a preparacao de uma variante da hirudina

Country Status (24)

Country Link
US (1) US5650301A (pt)
EP (1) EP0273800B1 (pt)
JP (1) JP2567263B2 (pt)
KR (1) KR960011918B1 (pt)
AT (1) ATE73462T1 (pt)
AU (1) AU617989B2 (pt)
BG (1) BG49719A3 (pt)
CA (1) CA1341416C (pt)
CS (1) CS276245B6 (pt)
DE (1) DE3777367D1 (pt)
DK (1) DK173247B1 (pt)
ES (1) ES2032465T3 (pt)
FI (1) FI99211C (pt)
FR (1) FR2607517B2 (pt)
GR (1) GR3004556T3 (pt)
HU (1) HU213871B (pt)
IE (1) IE60544B1 (pt)
MC (1) MC1884A1 (pt)
NO (1) NO177500C (pt)
PL (1) PL157254B1 (pt)
PT (1) PT86233B (pt)
RO (1) RO106890B1 (pt)
SU (1) SU1687032A3 (pt)
ZA (1) ZA879011B (pt)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2628429B1 (fr) * 1988-03-08 1990-12-28 Transgene Sa Variants de l'hirudine, leurs utilisations et les procedes pour les obtenir
GB8817161D0 (en) * 1988-07-19 1988-08-24 Ciba Geigy Ag Modified proteins
GB8817160D0 (en) * 1988-07-19 1988-08-24 Ciba Geigy Ag Novel proteins
US5284768A (en) * 1988-08-24 1994-02-08 Sanofi Signal peptide, DNA sequences coding for the latter, expression vectors carrying one of these sequences, gram-negative bacteria transformed by these vectors, and process for the periplasmic production of a polypeptide
US5879926A (en) * 1989-03-31 1999-03-09 Transgene S.A. Yeast strains for the production of mature heterologous proteins, especially hirudin
FR2645174B1 (fr) * 1989-03-31 1994-01-07 Transgene Sa Souches de levure ameliorees pour la production de proteines heterologues matures en particulier d'hirudine et procede de preparation d'hirudine correspondant
FR2645175B1 (fr) * 1989-03-31 1994-02-18 Transgene Sa Souche de saccharomyces cerevisiaeproductrice d'une proteine heterologue et procede de preparation de ladite proteine heterologue par fermentation de ladite souche
FR2646437B1 (fr) * 1989-04-28 1991-08-30 Transgene Sa Nouvelles sequences d'adn, leur application en tant que sequence codant pour un peptide signal pour la secretion de proteines matures par des levures recombinantes, cassettes d'expression, levures transformees et procede de preparation de proteines correspondant
FR2656531B1 (fr) * 1989-12-29 1992-04-24 Sanofi Sa Promoteur artificiel pour l'expression de proteines dans le levure.
US5118790A (en) * 1990-07-24 1992-06-02 Sri International Analogs of hirudin
ATE140929T1 (de) * 1990-11-08 1996-08-15 Japan Energy Corp Hirudinmutante, deren herstellung, antikoagulans, sekretorischer vektor, durch besagten vektor transformierter mikroorganismus und herstellung eines produkts durch besagten mikroorganismus
US5837808A (en) * 1991-08-20 1998-11-17 Baxter International Inc. Analogs of hirudin
US5407822A (en) * 1991-10-02 1995-04-18 Sanofi Artificial promoter for the expression of proteins in yeast
JP7375012B2 (ja) * 2019-04-16 2023-11-07 サンゲン バイオサイエンス カンパニー，リミテッド ヒルジン突然変異体の抽出・精製方法およびその使用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1341417C (fr) * 1984-03-27 2003-01-21 Paul Tolstoshev Vecteurs d'expression de l'hirudine, cellules transformees et procede de preparation de l'hirudine
EP0168342B1 (de) * 1984-06-14 1991-07-03 Ciba-Geigy Ag Verfahren zur Herstellung von Thrombin-Inhibitoren
DE3429430A1 (de) * 1984-08-10 1986-02-20 Hoechst Ag, 6230 Frankfurt Gentechnologisches verfahren zur herstellung von hirudin und mittel zur durchfuehrung dieses verfahrens
DE3445517C2 (de) * 1984-12-13 1993-11-18 Ciba Geigy Für ein Hirudin-ähnliches Protein codierende DNA-Sequenz und Verfahren zur Herstellung eines Hirudin-ähnlichen Proteins
FR2593518B1 (fr) * 1985-05-02 1989-09-08 Transgene Sa Vecteurs d'expression et de secretion de l'hirudine par les levures transformees
DE3689525D1 (de) * 1985-07-17 1994-02-24 Hoechst Ag Neue Polypeptide mit blutgerinnungshemmender Wirkung, Verfahren zu deren Herstellung bzw. Gewinnung, deren Verwendung und diese enthaltende Mittel.

Also Published As

Publication number Publication date
AU617989B2 (en) 1991-12-12
FI99211C (fi) 1997-10-27
NO874905D0 (no) 1987-11-25
CS276245B6 (en) 1992-05-13
BG49719A3 (en) 1992-01-15
DK173247B1 (da) 2000-05-22
EP0273800A2 (fr) 1988-07-06
KR880007729A (ko) 1988-08-29
PT86233B (pt) 1990-11-07
ATE73462T1 (de) 1992-03-15
DE3777367D1 (de) 1992-04-16
HUT45564A (en) 1988-07-28
FR2607517B2 (fr) 1989-12-22
GR3004556T3 (pt) 1993-04-28
JPS63152987A (ja) 1988-06-25
IE60544B1 (en) 1994-07-27
ZA879011B (en) 1988-05-27
CA1341416C (fr) 2003-01-21
EP0273800B1 (fr) 1992-03-11
CS8708732A2 (en) 1991-07-16
NO874905L (no) 1988-06-02
KR960011918B1 (ko) 1996-09-04
NO177500C (no) 1995-09-27
MC1884A1 (fr) 1989-01-24
DK627687D0 (da) 1987-11-30
FR2607517A2 (fr) 1988-06-03
FI875295A0 (fi) 1987-12-01
ES2032465T3 (es) 1993-02-16
PL269164A1 (en) 1988-08-18
HU213871B (en) 1997-11-28
FI99211B (fi) 1997-07-15
PL157254B1 (pl) 1992-05-29
DK627687A (da) 1988-06-02
JP2567263B2 (ja) 1996-12-25
US5650301A (en) 1997-07-22
SU1687032A3 (ru) 1991-10-23
EP0273800A3 (en) 1988-07-20
RO106890B1 (ro) 1993-07-30
IE873239L (en) 1988-06-01
FI875295A (fi) 1988-06-02
AU8188087A (en) 1988-06-02
NO177500B (no) 1995-06-19

Similar Documents

Publication Publication Date Title
MC1881A1 (fr) Derives de l'acide phosphinique
DK340088D0 (da) Aminosyrederivater
MA20648A1 (fr) Tensioactifs derives de l'acide citrique
DK565987D0 (da) Substituerede aminosyrer
FR2593513B1 (fr) Procede de production d'essence
FR2482426B1 (fr) Procede de preparation d'un succedane de blanc d'oeuf a base de proteine de soja
PT86233A (fr) Procede de preparation d:une variant de l:hirudine
EP0231996A3 (en) Novel amino acid derivatives
DK523288A (da) Aminosyrederivater
GB2177091B (en) 5,6-epoxy-7-oxabicycloheptane substituted amino prostaglandin analogs useful in the treatment of thrombotic disease
MC1960A1 (fr) Derives d'acide hydrocinnamique
NO178325C (no) Fremgangsmåte for fremstilling av et t-PA injeksjonspreparat
IT1188557B (it) Acidi 8-osso-2-ossa-1-azabiciclo (4.2.0)ottano-3-carbossilici
PT86931A (pt) Procede de preparation de polychlorophosphazene
DE68908843T2 (de) Verfahren zur Herstellung von 4,6-Dimethyl-7-hydroxynonan-3-on.
DE68914950D1 (de) Aminsalze von 1,4,2-Oxazaphospholidin-2-alkoxy-2-oxid-4-essigsäuren.
PT83116B (pt) Processo para a preparacao de acidos 5-cloro-s-triazolo{4,3-a}-piridino-7-carboxilicos
FR2591221B1 (fr) Procede de preparation d'a-aminoacides
RO89760A2 (ro) Procedeu de obtinere a aminoacizilor
RO93222A2 (ro) Procedeu pentru obtinerea acidului 1,4-dihidroxi-2-naftoic

Legal Events

Date Code Title Description
PC3A Transfer or assignment

Free format text: SCHERING AKTIENGESELLSCHAFT DE

Effective date: 20021002

TE3A Change of address (patent)

Free format text: TRANSGENE S.A. FR

Effective date: 20021002